Nepom Injection (Nepopam Hydrochloride)

Adult administration

Administer 20 mg of nefopam hydrochloride by intramuscular or intravenous injection. If necessary, repeat every 6 hours, not exceeding 120 mg per day. Administer intravenous injections slowly over at least 15 minutes. After administration, it is advisable to have the patient lie still and rest for 15-20 minutes. If added to an infusion such as electrolytes or glucose, administer 30 mg over 4 hours or 40 mg over 6-8 hours, in proportion to the infusion time. It is recommended that this medicine not be mixed with other medicines for injection. Adjust the dose appropriately according to age and symptoms.

This medication may contain glass fragments when using the ampoule; therefore, caution should be exercised when cutting the glass ampoule for safe usage. This medication should not be used in patients with epilepsy, myocardial infarction, those taking certain antidepressants or MAO inhibitors, allergic reactions, children under 15 years of age, patients with a history of seizures, those with urinary retention due to urethra and prostate issues, and patients with angle-closure glaucoma. Elderly patients, pregnant or breastfeeding women, and patients taking anticholinergic medications should use this medication with increased caution. This medication may cause various side effects such as loss of appetite, nausea, drowsiness, vomiting, excessive sweating, dizziness, rapid heartbeat, dry mouth, urinary retention, pain at the injection site, headache, blurred vision, fatigue, irritability, sleep disturbances, insomnia, excitement, hallucinations, drug abuse and dependence, seizures, and allergic reactions. This medication is a therapeutic agent for reducing inflammation or pain and does not treat the underlying cause; thus, symptoms and conditions should be closely monitored during use. In cases of inflammation induced by infections, it should be administered with appropriate antibiotics or antifungals with caution. In elderly patients, the smallest effective dose should be used, and special attention should be paid to the occurrence of side effects. Patients with liver or kidney dysfunction may be affected by the metabolism and excretion of this medication, so caution is necessary. This medication may cause drowsiness or reduced concentration; therefore, it is advisable to avoid using it while driving or operating hazardous machinery. When used in conjunction with other analgesics or certain neurological medications, the risk of side effects may increase, so it is important to consult a physician before combined administration. The use of this medication is not recommended for pregnant or breastfeeding women, and it is not recommended for children due to the lack of confirmed safety and efficacy. In cases of overdose, consult medical personnel immediately, and careful monitoring of the heart and respiratory status may be required. It is advisable to avoid mixing this medication with other drugs for injection and to store it away from direct sunlight in a cool, dry place. Additionally, keep it out of reach of children and avoid transferring it to other containers.

• appetite loss
• gastrointestinal disorders
• nausea
• drowsiness
• vomiting
• excessive sweating
• dizziness
• tachycardia
• palpitations
• thirst

This medication should be stored in a sealed container to prevent air and moisture entry and is best kept at room temperature between 1 and 30 degrees Celsius. This storage method will help maintain the medication's effectiveness for a long time.

Appearance

A colorless and transparent injection solution in a colorless and transparent glass ampoule with no odor

Package unit

2mL/ampoule X 10 pieces